Dimensional Fund Advisors LP Ligand Pharmaceuticals Inc Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 523,913 shares of LGND stock, worth $105 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

523,913

Previous 704,522 25.64%

Holding current value

$105 Million

Previous $80.1 Million 15.88%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$112.56 - $177.14 $20.3 Million - $32 Million	-180,609 Reduced 25.64%	523,913 $92.8 Million
Q2 2025 Aug 12, 2025	SELL	$96.67 - $118.22 $3.91 Million - $4.78 Million	-40,408 Reduced 5.42%	704,522 $80.1 Million
Q1 2025 May 13, 2025	BUY	$105.14 - $122.23 $2.3 Million - $2.68 Million	21,911 Added 3.03%	744,930 $78.3 Million
Q4 2024 Feb 13, 2025	BUY	$99.95 - $129.9 $1.6 Million - $2.08 Million	16,003 Added 2.26%	723,019 $77.5 Million
Q3 2024 Nov 07, 2024	SELL	$82.7 - $110.11 $132,981 - $177,056	-1,608 Reduced 0.23%	707,016 $70.8 Million

Q2 2024 Aug 09, 2024	BUY	$68.53 - $87.91 $3.05 Million - $3.92 Million	44,543 Added 6.71%	708,624 $59.7 Million
Q1 2024 May 10, 2024	BUY	$68.64 - $89.2 $191,025 - $248,243	2,783 Added 0.42%	664,081 $48.5 Million
Q4 2023 Feb 07, 2024	BUY	$49.57 - $72.63 $2.33 Million - $3.41 Million	46,906 Added 7.63%	661,298 $47.2 Million
Q3 2023 Nov 09, 2023	BUY	$58.86 - $72.67 $4.88 Million - $6.03 Million	82,970 Added 15.61%	614,392 $36.8 Million
Q2 2023 Aug 09, 2023	BUY	$69.53 - $79.33 $4.28 Million - $4.88 Million	61,506 Added 13.09%	531,422 $38.3 Million
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $787,580 - $924,420	11,993 Added 2.62%	469,916 $34.6 Million
Q4 2022 Feb 09, 2023	BUY	$61.72 - $96.74 $543,444 - $851,795	8,805 Added 1.96%	457,923 $30.6 Million
Q3 2022 Nov 10, 2022	BUY	$0.01 - $107.56 $64 - $689,889	6,414 Added 1.45%	449,118 $38.7 Million
Q2 2022 Aug 12, 2022	BUY	$74.52 - $117.06 $4.81 Million - $7.56 Million	64,586 Added 17.08%	442,704 $39.5 Million
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $517,695 - $826,002	5,450 Added 1.46%	378,118 $42.5 Million
Q4 2021 Feb 09, 2022	SELL	$127.69 - $165.85 $13,535 - $17,580	-106 Reduced 0.03%	372,668 $57.6 Million
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $3.75 Million - $5.3 Million	-36,603 Reduced 8.94%	372,774 $51.9 Million
Q2 2021 Aug 12, 2021	BUY	$113.03 - $155.64 $5.33 Million - $7.33 Million	47,120 Added 13.01%	409,377 $53.7 Million
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $351,703 - $762,743	-3,534 Reduced 0.97%	362,257 $55.2 Million
Q4 2020 Feb 25, 2021	BUY	$80.55 - $106.05 $29.5 Million - $38.8 Million	365,791 New	365,791 $36.4 Million

Others Institutions Holding LGND

# of Institutions

343

Shares Held

20.5M

Call Options Held

19K

Put Options Held

11.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Ligand Pharmaceuticals Inc Transaction History